Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Founded in 2020, Asalyxa Bio is a spinout from the University of Michigan, focused on the rapid development of a new neutrophil-targeting drug platform. Neutrophils are immune cells that are involved in the systemic response to infection and injury. Asalyxa’s proprietary platform allows for the direct delivery of microparticles into neutrophils, making the platform suitable […]
Macomics is a UK-based start-up focused on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defence against tumours. Macomics’ approach is based on leading academic research around macrophage biology, particularly in cancer, from the laboratory of Professor Jeffrey Pollard, Director of the MRC Centre for Reproductive Health at the […]
Founded in 2020, Lino Biotech is a Switzerland-based startup commercializing a biosensor platform developed by Roche & ETH Zurich. The company says is the world’s only provider of Focal Molography – a novel label-free biosensor platform for direct imaging of biomolecular interactions in living cells. Molography enables customer from the pharma industry to measure binding […]